oral tirzepatide studies TrimRX Semaglutide vs. Tirzepatide for Obesity

Anything beyond that needs stronger evidence

Washout approach (more common): Administer final Wegovy dose Wait 7 to 10 days (approximately 1.5 half-lives) Start Zepbound 2.5 mg Rationale: minimizes overlapping GLP-1 receptor activation, reduces nausea risk Overlap approach (less common, used when continuous appetite suppression is critical): Administer final Wegovy dose Start Zepbound 2.5 mg 3 to 4 days later Rationale: prevents gap in therapeutic effect during washout Risk: higher nausea and GI side effect burden during overlap window Most providers use washout

GLP-1 directly activates appetite-control pathways in the brain and slows stomach emptying, triggering significant hunger reduction and sustained weight loss

For most people, the real challenge isnt losing weight its keeping it off

Free delivery over INR 2000/- GMP certified, FSSAI certified